EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Syringic Acid Alleviates Doxorubicin-Induced Hepatotoxicity Through PI3K/Akt-Mediated Nrf-2/HO-1 Signaling Pathways in Male Rats

Maha Abdullah Alwaili, Thamir M Eid iD, Amal S Abu-Almakarem, Alaa Muqbil Alsirhani, Noorah Saleh Al-Sowayan iD, Rabab Mohamed Aljarari, Effat A Al-Judaibi, Aljazi Abdullah AlRashidi, Maysa A Mobasher iD, Karim Samy El-Said iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maha Abdullah Alwaili und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia. Hauptthemen laut MEDLINE: Doxorubicin, Signal Transduction, NF-E2-Related Factor 2, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syringic acid (SYA) is a significant phenolic compound with the potential for various biomedical uses, including uses of its hepatoprotective properties. Doxorubicin (DOX) is a drug used in the treatment of several tumors, but its side effects, particularly hepatotoxicity, limit its effectiveness. This study investigated the therapeutic effects of SYA on DOX-induced hepatic injury in rats. Molecular docking studies were performed using AutoDock Vina. Five groups of Sprague–Dawley rats (eight in each group) were studied. Gp1 was a negative control group; Gps2–5 was administered intraperitoneally (i.p.) with DOX at a dosage of 4 mg/kg once a week for a month; and Gp2 was left as a positive control group. Gps3–5 received oral SYA at doses of 25, 50, or 75 mg/kg/day, respectively, for a month. Histopathological, molecular, and biochemical analyses were conducted one month after the last SYA dosages were given. The findings demonstrated that by reversing biochemical changes and reducing oxidative stress and inflammation, SYA therapy considerably reduced DOX-induced hepatotoxicity in rats. These results implied that SYA may lessen the hepatotoxicity that DOX causes in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinSignal TransductionNF-E2-Related Factor 2Chemical and Drug Induced Liver InjuryGallic AcidAnimalsMaleProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyOxidative StressPhosphatidylinositol 3-KinasesMolecular Docking SimulationLiverHeme Oxygenase (Decyclizing)Heme Oxygenase-1

Stichwörter der Autor:innen

anti-inflammatoriesantioxidantsdoxorubicinhepatotoxicitysyringic acid

Substanzen

DoxorubicinProto-Oncogene Proteins c-aktNF-E2-Related Factor 2syringic acidPhosphatidylinositol 3-KinasesGallic AcidNfe2l2 protein, ratHmox1 protein, ratHeme Oxygenase (Decyclizing)Heme Oxygenase-1

Autor:innen und Institutionen

  • Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
  • Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Experimental Biochemistry Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65525, Saudi Arabia.
  • Department of Chemistry, College of Science, Jouf University, Sakaka 72341, Saudi Arabia.
  • Department of Biology, College of Science, Qassim University, Buraidah 52377, Saudi Arabia.

ORCID-Profile: Thamir M Eid, Noorah Saleh Al-Sowayan, Maysa A Mobasher, Karim Samy El-Said

Förderung

  • Princess Nourah bint Abdulrahman University

Zitieren

APA

Alwaili, M. A., Eid, T. M., Abu-Almakarem, A. S., Alsirhani, A. M., Al-Sowayan, N. S., Aljarari, R. M., Al-Judaibi, E. A., AlRashidi, A. A., Mobasher, M. A., & El-Said, K. S. (2025). Syringic Acid Alleviates Doxorubicin-Induced Hepatotoxicity Through PI3K/Akt-Mediated Nrf-2/HO-1 Signaling Pathways in Male Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167779

Vancouver

Alwaili MA, Eid TM, Abu-Almakarem AS, Alsirhani AM, Al-Sowayan NS, Aljarari RM, et al. Syringic Acid Alleviates Doxorubicin-Induced Hepatotoxicity Through PI3K/Akt-Mediated Nrf-2/HO-1 Signaling Pathways in Male Rats. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167779

BibTeX
@article{Alwaili2025,
  author = {Alwaili, Maha Abdullah and Eid, Thamir M and Abu-Almakarem, Amal S and Alsirhani, Alaa Muqbil and Al-Sowayan, Noorah Saleh and Aljarari, Rabab Mohamed and Al-Judaibi, Effat A and AlRashidi, Aljazi Abdullah and Mobasher, Maysa A and El-Said, Karim Samy},
  title = {Syringic Acid Alleviates Doxorubicin-Induced Hepatotoxicity Through PI3K/Akt-Mediated Nrf-2/HO-1 Signaling Pathways in Male Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167779}
}
Kostenlos starten →